Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05336942
Other study ID # PKJ2019-Y24
Secondary ID
Status Completed
Phase
First received
Last updated
Start date November 1, 2020
Est. completion date March 30, 2022

Study information

Verified date April 2022
Source Tongji University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Cognitive dysfunction is a high incidence disease in the elderly. To date, there is no effective treatment. At the same time, early cognitive impairment is easy to be ignored, delayed intervention. Most patients develop moderate or severe dementia with hearing loss before treatment. At present, there are few studies on the correlation between mild cognitive impairment and hearing function. The investigators evaluated CDR, MMSE, MoCa, and hearing tests at baseline, 6 months later, and 12 months later in a multicenter, randomized cohort study of adults aged 55-65 years. To investigate the correlation between mild cognitive impairment and hearing impairment and its possible predictors. The investigators hope to provide more evidence-based evidence for early identification of mild cognitive impairment.


Description:

With the aging of society, the health of the elderly has paid more and more attention. Cognitive dysfunction has always been a common disease that seriously affects the quality of life of the elderly, thus increasing the burden of family and society. How to prevent and slow down cognitive dysfunction is a topic worthy of discussion, but so far, there is no safer and effective method to solve this problem. Cognitive function refers to various conscious mental activities of human beings in the state of awakening, including reception function, namely receiving external information through various senses, memory and learning function, thinking function and expression function. Mild cognitive impairment (MCI) is the early stage of Senile dementia and a cognitive loss state between normal aging and dementia. The reception function of sensory organs is the basis of the whole cognitive activity and the initial stage of cognitive function, so there is a close relationship between sensation and cognitive function. Studies have shown that hearing impairment is an independent risk factor for cognitive impairment, hearing loss is positively correlated with cognitive impairment, and senile MCI is significantly correlated with hearing impairment, both of which exist a dose-effect relationship and complement each other. Especially in people over 50 years old, hearing impairment has a high incidence of cognitive impairment, and hearing impairment is an influential factor of cognitive function. There is a certain correlation between hearing loss and cognitive function. Bai Jie et al. analyzed the MMSE, MoCA, drawing clock test and daily living ability Assessment Scale of the normal hearing group and the untreated senile deafness group, and showed that hearing loss would lead to cognitive impairment, mainly for two reasons: (1) People with presbyopia do not have a good understanding of the tasks to be performed; (2) Presbyopia causes social isolation and cognitive decline. American Medical Association (ASA) study included 1,884 subjects, of whom 1,162 had presbyage-related deafness, and the results showed that these patients had lower cognitive function than normal hearing subjects. They believe that the reason is that both senile deafness and cognitive decline occur in the same neural source. Therefore, it is worth exploring whether cognitive function can be delayed and improved by improving hearing. There are a large number of people over 60 years old with hearing impairment. According to the Chinese Epidemiological survey, 35-55% of people over 60 years old suffer from different degrees of hearing impairment. But as most of the older hearing impairment is a process of gradual development, thus can be considered as a immutable physiological process, and this is a kind of don't want to expose himself, and is hard to see someone invisible disability, therefore, are easily ignored by others, resulting in social communication, interpersonal communication between the obstacle, thus reducing the social function of old people. To date, there are few prospective studies on the relationship between hearing impairment and cognitive impairment. This research through the community elderly were followed up for 1 year, evaluation of hearing loss and the correlation between prognosis of mild cognitive function impairment, focus on community elderly hearing impairment and the relationship between the cognitive dysfunction, to strengthen the science popularization of the old man, so that more older people can focus on listening and impaired cognitive function, active intervention, In this way, the quality of life of the elderly can be improved, social communication can be promoted, life satisfaction of the elderly can be improved, and family and social burden can be reduced.


Recruitment information / eligibility

Status Completed
Enrollment 90
Est. completion date March 30, 2022
Est. primary completion date December 30, 2021
Accepts healthy volunteers
Gender All
Age group 55 Years to 65 Years
Eligibility Inclusion Criteria: 1. The registered residence of local residents is more than one month. 2. Aged 55 to 65 years. 3. Be able to conduct verbal communication or written conversation, or complete the investigation with the help of family members. Exclusion Criteria: 1. Mini-mental state examination(MMSE), illiterate group = 17 points, primary school group = 20 points, middle school or above group 24 points; 2. Those who meet the ICD-10 diagnostic criteria for dementia; 3. Those who are obviously blind or have difficulty in speech expression; 4. Persons suffering from serious physical diseases; 5. Those who meet the diagnostic criteria of schizophrenia, neurosis, organic mental disorder and mental retardation; 6. Persons with severe or above hearing impairment; 7. Those who are unable to sign the informed consent form.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
China Tongji University Shanghai

Sponsors (1)

Lead Sponsor Collaborator
Tongji University

Country where clinical trial is conducted

China, 

References & Publications (7)

Heywood R, Gao Q, Nyunt MSZ, Feng L, Chong MS, Lim WS, Yap P, Lee TS, Yap KB, Wee SL, Ng TP. Hearing Loss and Risk of Mild Cognitive Impairment and Dementia: Findings from the Singapore Longitudinal Ageing Study. Dement Geriatr Cogn Disord. 2017;43(5-6):2 — View Citation

Jongsiriyanyong S, Limpawattana P. Mild Cognitive Impairment in Clinical Practice: A Review Article. Am J Alzheimers Dis Other Demen. 2018 Dec;33(8):500-507. doi: 10.1177/1533317518791401. Epub 2018 Aug 1. Review. — View Citation

Khan HZ, Park CY, Lim MA, Beltran AJ, Farquhar D, Yencha M, Capra GG. Radiographic findings in young adults with asymmetric sensorineural hearing loss. Am J Otolaryngol. 2019 Jan - Feb;40(1):78-82. doi: 10.1016/j.amjoto.2018.10.003. Epub 2018 Oct 11. — View Citation

Lin FR, Yaffe K, Xia J, Xue QL, Harris TB, Purchase-Helzner E, Satterfield S, Ayonayon HN, Ferrucci L, Simonsick EM; Health ABC Study Group. Hearing loss and cognitive decline in older adults. JAMA Intern Med. 2013 Feb 25;173(4):293-9. doi: 10.1001/jamain — View Citation

Maharani A, Pendleton N, Leroi I. Hearing Impairment, Loneliness, Social Isolation, and Cognitive Function: Longitudinal Analysis Using English Longitudinal Study on Ageing. Am J Geriatr Psychiatry. 2019 Dec;27(12):1348-1356. doi: 10.1016/j.jagp.2019.07.0 — View Citation

Ringman JM, Medina LD, Rodriguez-Agudelo Y, Chavez M, Lu P, Cummings JL. Current concepts of mild cognitive impairment and their applicability to persons at-risk for familial Alzheimer's disease. Curr Alzheimer Res. 2009 Aug;6(4):341-6. — View Citation

Srikanth V, Sinclair AJ, Hill-Briggs F, Moran C, Biessels GJ. Type 2 diabetes and cognitive dysfunction-towards effective management of both comorbidities. Lancet Diabetes Endocrinol. 2020 Jun;8(6):535-545. doi: 10.1016/S2213-8587(20)30118-2. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Mini-mental state examination (MMSE) To screen and assess the extent of cognitive dysfunction. Baseline
Primary Mini-mental state examination (MMSE) To screen and assess the extent of cognitive dysfunction. 6-month
Primary Mini-mental state examination (MMSE) To screen and assess the extent of cognitive dysfunction. 12-month
Primary Montreal Cognitive Assessment (MocA) To evaluate various domains of cognition. Baseline
Primary Montreal Cognitive Assessment (MocA) To evaluate various domains of cognition. 6-month
Primary Montreal Cognitive Assessment (MocA) To evaluate various domains of cognition. 12-month
Primary Pure tone Listening Test (PTA) To determine the threshold intensity of hearing at each frequency and measure the nature and extent of hearing loss. Baseline
Primary Pure tone Listening Test (PTA) To determine the threshold intensity of hearing at each frequency and measure the nature and extent of hearing loss. 6-month
Primary Pure tone Listening Test (PTA) To determine the threshold intensity of hearing at each frequency and measure the nature and extent of hearing loss. 12-month
Secondary Clinical Dementia Rating (CDR) To generated to stage the severity of dementia. Baseline
Secondary Clinical Dementia Rating (CDR) To generated to stage the severity of dementia. 6-month
Secondary Clinical Dementia Rating (CDR) To generated to stage the severity of dementia. 12-month
Secondary Auditory brainstem response (ABR) To evaluate objectively the hearing level by the response threshold of V wave. Baseline
Secondary Auditory brainstem response (ABR) To evaluate objectively the hearing level by the response threshold of V wave. 6-month
Secondary Auditory brainstem response (ABR) To evaluate objectively the hearing level by the response threshold of V wave. 12-month
See also
  Status Clinical Trial Phase
Completed NCT04513106 - Promoting Advance Care Planning for Persons With Early-stage Dementia in the Community: a Feasibility Trial N/A
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Recruiting NCT04522739 - Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease Phase 4
Active, not recruiting NCT03167840 - Falls Prevention Through Physical And Cognitive Training in Mild Cognitive Impairment N/A
Active, not recruiting NCT03676881 - Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
Not yet recruiting NCT05041790 - A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment Phase 4
Recruiting NCT04121156 - High Definition Transcranial Direct Current Stimulation (HD-tDCS) in Patients With Mild Cognitive Impairment N/A
Recruiting NCT03605381 - MORbidity PRevalence Estimate In StrokE
Completed NCT02774083 - Cognitive Training Using Feuerstein Instrumental Enrichment N/A
Completed NCT01315639 - New Biomarker for Alzheimer's Disease Diagnostic N/A
Enrolling by invitation NCT06023446 - Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?
Completed NCT04567745 - Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers Phase 1
Recruiting NCT05579236 - Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease
Completed NCT03583879 - Using Gait Robotics to Improve Symptoms of Parkinson's Disease N/A
Terminated NCT02503501 - Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease Phase 2
Not yet recruiting NCT03740178 - Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005) Phase 1
Active, not recruiting NCT05204940 - Longitudinal Observational Biomarker Study
Recruiting NCT02663531 - Retinal Neuro-vascular Coupling in Patients With Neurodegenerative Disease N/A
Recruiting NCT06150352 - Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
Recruiting NCT03507192 - Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia. N/A